Oligometastatic Breast Cancer: Is This a Curable Entity? A Contemporary Review of the Literature.

ABSTRACT:

Purpose of review

Oligometastatic breast cancer (OMBC) remains a poorly understood entity for which no standard of care exists at this time. This review will focus on our biologic understanding of OMBC and provide an update on current treatment strategies.

Recent findings

The introduction of micro RNA expression profiling has advanced our understanding of the biologic underpinnings of OMBC. Although most of the data regarding treatment have come from retrospective studies, there are now prospective randomized trials reporting progression-free survival and overall survival improvements with stereotactic ablative radiotherapy (SABR). Ongoing studies designed to evaluate addition of SABR as well as other novel agents will further develop this field and provide new treatment opt

SUBMITTER: Makhlin I 

PROVIDER: S-EPMC7219961 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature